U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893535) titled 'An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid Tumors' on Oct. 19.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of BON-106 in adults with advanced or metastatic solid tumors.
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Advanced Solid Tumor
Metastatic Solid Tumor
Intervention:
DRUG: BON-106
Administered by intravenous infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: BeOne Medicines
Published by HT Digital Content Services with permission from Health Daily ...